Search results
Results From The WOW.Com Content Network
The falling share price has pushed the stock's dividend yield to nearly 6%. ... In other words, Pfizer's next growth phase could already be starting. This growth should support the dividend.
In contrast to AbbVie, Pfizer (NYSE: PFE) stands out as more of a turnaround opportunity, offering investors the chance to pick up shares in a pharmaceutical industry leader at a discount, down ...
Pharmaceutical giant Pfizer (NYSE: PFE) stands out in this context. The company currently offers a mouthwatering 5.7% dividend yield -- the highest among major drug manufacturers and one of the ...
A high-yield dividend stock with long-term potential Pfizer's current 5.73% dividend yield stands well above the S&P 500 average of 1.35%. The company's payout ratio of 443% appears unsustainable ...
The good news on this front, though, is that Pfizer is poised to improve its bottom line and make its dividend even safer. Sure, the big pharma company's earnings fell 11% year over year in Q2.
With a lot of new drugs to sell, Pfizer expects adjusted earnings to reach a range between $2.15 and $2.35 per share this year, which is more than it needs to meet a dividend commitment currently ...
For premium support please call: 800-290-4726 more ways to reach us
Pfizer stock currently has a 5.9% dividend yield, making it an attractive target for income investors. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 more ways to ...